M ammalian cells acquire cholesterol either through de novo synthesis or by receptormediated endocytosis of lipoprotein cholesterol via specific, saturable, high-affinity lipoprotein receptors. Most of these receptor pathways are regulated by the cellular cholesterol levels, and when these increase, three metabolic responses occur to maintain cholesterol homeostasis: 1) downregulation of low density lipoprotein (LDL) receptors at the transcriptional level; 2) suppression of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the rate limiting enzyme of cholesterol biosynthesis; and 3) induction of acyl-coenzyme A cholesterol acyltransferase (ACAT) activity, ACAT being the enzyme responsible for cholesterol esterification. 
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Histochemical analyses, electron microscopy studies, and the presence of surface markers of human lesions have implicated tissue macrophages in the development of foam cells that occur during the process of atherosclerosis in humans. 8 In vitro and genetic studies indicate that lipoprotein uptake via the LDL receptor is probably not a major factor in foam cell development and that the two most likely mechanisms by which macrophages accumulate cholesteryl ester are either by LDL uptake via a lowaffinity, non-receptor-mediated pathway or by uptake of modified LDL via a high-affinity, scavenger receptor-mediated pathway. Macrophages, the major cellular components of atherosclerotic plaques, possess unique and specific characteristics. In vitro differentiation of blood monocytes to macrophages is associated with a decrease in LDL receptor activity, enhanced scavenger receptor activity, and secretion of lipoprotein lipase and apolipoprotein (apo) E.
HMG-CoA reductase activity 10 and receptor-mediated LDL degradation. 11 TPA-induced differentiation of HL-60 cells has been reported to block receptor-mediated LDL degradation 11 and to increase sterol synthesis rates and HMG-CoA reductase activity. 12 Differentiation of HL-60 cells with TPA is also accompanied by induction of the apo E gene. 9 In contrast to the available data regarding the effects of TPA-induced macrophage differentiation on HL-60 cells, little is known regarding the effects of D 3 -induced differentiation on lipid and lipoprotein metabolism by these cells. In many aspects D 3 -induced HL-60 macrophages exhibit metabolic patterns similar to those reported for human monocytederived macrophages. 111314 In an attempt to develop a model system for in vitro analysis of the interactions between human plasma lipoproteins and human macrophages, studies were performed to characterize the lipoprotein receptors of the human promyelocytic leukemia cell line HL-60 before and after induction of macrophage differentiation by TPA or D 3 . Our results demonstrate that HL-60 cells exhibit a specific, saturable, and regulated LDL receptor, with no expression of a scavenger receptor for chemically modified LDL. Macrophage differentiation of HL-60 cells by TPA resulted in the loss of receptormediated LDL degradation and no measurable degradation of acetylated LDL (acetyl-LDL). In contrast, D 3 -induced HL-60 macrophages express specific and saturable receptors for both LDL and acetyl-LDL. These data suggest that D 3 -induced HL-60 macrophages can be a valuable model system for in vitro studies of human lipoprotein-macrophage interaction and its regulation, as related to foam cell development and atherogenesis.
Methods Materials HL-60 cells were obtained from the American Type Culture Collection, Rockville, Md.; iodine-125-labeled Nal was purchased from Amersham, Arlington Heights, 111.; RPMI-1640, glutamine, penicillin/ streptomycin, horse serum (HS), and fetal calf serum (FCS) were purchased from Flow Labs, McLean, Va.; TPA (dissolved in acetone and stored at -80°C), chloroquine, pronase (103 PUK/mg, where 1 PUK of enzyme will liberate folin-positive amino acids and peptides equivalent to an absorbance change of 1.0 within 10 minutes under assay conditions), bovine serum albumin (BSA), mezerein (dissolved in ethanol and stored at -20°C), and nonspecific acid esterase were from Sigma Chemical Co., St. Louis, Mo.; D 3 (stored in small aliquots in ethanol at -20°C) was the gift of Milan R. Uskokovic, Hoffman-LaRoche, Inc., Nutley, N.J.; and mevinolin was a gift of Al Alberts, Merck Sharp & Dohme, Nutley, N.J. [l, [2] [3] H]cholesterol (60 Ci/mmol) and carbon-14-labeled acetate ( [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]acetate, 55 mCi/mmol) were obtained from New England Nuclear Corp., Boston, Mass.; heparinSepharose affinity columns were purchased from Pharmacia, Piscataway, N.J.; and neutral alumina AG 7 (100-200 mesh) was obtained from Bio-Rad Laboratories, Richmond, Calif.
HL-60 Cell Culture
Human promyelocytic leukemic HL-60 cells were grown in RPMI-1640 supplemented with 15% heatinactivated HS, 24 mM NaHCO 3 , 2 mM L-glutamine, 100 units/ml penicillin, and 100 /ig/ml streptomycin in a humidified incubator of 5% CO 2 at 37°C. Cells were maintained by passage of 1.5 x 10 6 cells/ml every 3 days. Cell viability was determined by trypan blue exclusion.
Macrophage Differentiation
HL-60 cells (l.OxlO 6 cells/ml) maintained for 24 hours in fresh RPMI-1640 medium containing 15% HS were centrifuged for 10 minutes at 400g at 4°C and resuspended at a density of l.OxlO 6 cells/ml in RPMI-1640 medium containing 15% heat-inactivated lipoprotein-deficient FCS (LPDS). 15 To induce macrophage differentiation, 5.0xlO" 8 M D 3 or 1.5 xlO" 6 M TPA was added to the cells. After a 48-hour incubation at 37°C, the suspended cells were discarded; adherent cells were washed twice with phosphate-buffered saline (PBS), detached with PBS/1 mM EDTA buffer, scraped with a rubber policeman, centrifuged at 400g for 10 minutes at 4°C, washed twice with PBS, resuspended in PBS to a density of 1.5-2.0xl0 6 cells/ml, and used in the various experiments.
Lipoprotein Isolations
Plasma from normolipidemic volunteers recruited from staff and students at the University of Arizona was used to isolate very low density lipoproteins (VLDLs) (d< 1.006 g/ml), LDLs (d=1.02-1.063 g/ml), and high density lipoproteins (HDLs) (d=1.063-1.21 g/ml) by sequential ultracentrifugation at 15°C. 16 Lipoproteins were dialyzed at 4°C against a buffer of 0.15 M NaCl and 3 mM EDTA (pH 7.4) for 24 hours before use. To isolate apo E-free HDLs, density-fractionated HDL was subjected to heparin-Sepharose affinity chromatography. 17 LPDS was prepared from the d>1.23 g/ml fraction according to the method of Mills et al. 18 
Acetylation and Radiolabeling of Low Density Lipoprotein
LDL was acetylated with acetic anhydride 19 and was dialyzed against an NaCl-EDTA buffer for 24 hours at 4°C. Electrophoresis of the modified LDL on agarose gels at pH 8.6 demonstrated enhanced mobility toward the cathode compared with that of native LDL.
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I labeling of LDL and acetyl-LDL was performed according to the method of McFarlane 20 as modified by Goldstein et al. 21 Radiolabeled lipoproteins (350-500 cpm/ng) were stored at 4°C in 3% human albumin to minimize autoradiation denaturation, and the preparations were used within 3 weeks.
Analysis of Low Density Lipoprotein and Acetylated Low Density Lipoprctein Degradation Rates
Rates of lipoprotein degradation by HL-60 cells and D 3 -or TPA-induced HL-60 macrophages were determined by the method of Chait et al. 22 In brief, 10 /xg/ml 125 I-LDL or 125 I-acetyl-LDL were incubated with 0.4-0.5 xlO 6 cells/ml in the presence of 50 mm CaCl 2 and 15% LPDS at 37°C with (nonspecific degradation) or without (total degradation) a 20-fold excess of unlabeled native or acetyl-LDL. Reactions were terminated after 4 hours by addition of 0.5 ml 50% (wt/vol) trichloroacetic acid (TCA) and microfuged for 1 minute. After centrifugation, 0.25 ml 10% (wt/vol) AgNO 3 was added to the supernatant to precipitate free 125 I.23 TCA-soluble radioactivity was determined by use of a gamma counter. Receptor-mediated specific degradation was calculated as the difference between nonspecific and total degradation.
Competition Assays
Competition studies of 125 I-LDL degradation (10 )u,g/ml) were performed in the presence of 0, 50, 100, and 200 jig/ml protein of VLDL, LDL, acetyl-LDL, total HDL, and apo E-free HDL.
Measurement of Sterol Synthesis Rates
For analysis of sterol synthesis rates, HL-60 and D 3 -induced HL-60 macrophages were cultured for 48 hours in 15% LPDS. During the last 24 hours of incubation, 100 /u,g/ml of either LDL or acetyl-LDL was added to the culture media. Cells were collected, washed three times with PBS, and resuspended in PBS. Cells (1.0xlO 6 ) were incubated with 2.5 mM (5 dpm/pmol) [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]acetate for 4 hours at 37°C. 24 One milliliter of 50% KOH was added to terminate the reaction, followed by addition of [ 3 H]cholesterol (40,000 dpm) as an internal recovery standard; the samples were saponified at 70°C for 1 hour. Sterols were extracted with petroleum ether, passed through alumina AG 7 columns (100-200 mesh), and eluted with acetone/diethyl ether (1:1) as previously described. 24 The incorporation rate of [ 14 C]acetate into sterols was determined by scintillation counting and is expressed as nanomoles acetate incorporated per milligram cell protein per 4-hour incubation.
Other Assays
Calcium dependence of LDL and acetyl-LDL degradation was determined in the absence or presence of 2 mM calcium after washing the cells three times with calcium-free or calcium-containing PBS, respectively. To ensure cellular calcium depletion, degradation assays were performed with an incubation mixture containing 1 mM of the chelating agent EDTA. For pronase sensitivity analysis, cells were pretreated with 3 /xg/ml pronase for 20 minutes and washed three times with PBS. Chloroquine sensitivity was determined by pretreatment of cells with 50 mM chloroquine for 1 hour and measurement of 125 Ilipoprotein degradation in the presence of 50 mM chloroquine. Competition studies with fucoidin (10 /xg/ml) were determined for acetyl-LDL degradation in D 3 -induced HL-60 macrophages. 25 For studies of the effect of mezerein, HL-60 cells were incubated with 7.0xlO" 8 M mezerein for 48 hours, followed by measurements of LDL degradation rates.
Nonspecific esterase was determined by use of a-naphthyl acetate as a substrate and fast RR blue as the chromogen. 26 Protein concentrations were determined by a modified Lowry procedure 27 calibrated against BSA.
Statistical Analysis
One-way analysis of variance (ANOVA) was used to determine significant difference between treatments. 28 Data are presented as mean±SD for the number of assays shown.
Results

Macrophage Differentiation
Induction of differentiation of HL-60 cells to macrophages by either TPA or D 3 was confirmed by positive acid-esterase activity. TPA-treated HL-60 cells had prominent pseudopodia and exhibited intense adherence to plastic dishes as well as to each other. In contrast, D 3 -induced HL-60 macrophages adhered to plastic dishes without adhering to each other. Both TPA-and D 3 -induced HL-60 macrophages lost their proliferative capacity.
Low Density Lipoprotein and Acetylated Low Density Lipoprotein Degradation Rates
HL-60 cells incubated in 15% LPDS for 48 hours exhibited specific, saturable, receptor-mediated degradation of LDL ( Figure 1A ). Kinetic analysis of the saturation curve indicated that the apparent saturation point was approximately 15 ju,g/ml LDL. Highaffinity, receptor-mediated LDL degradation accounted for more than 85% of the total LDL degradation rate of HL-60 cells. Regulation of LDL degradation rates was demonstrated by incubating cells with 100 /ig/ml LDL for 24 hours, which resulted in a significant 86% reduction in the rate of LDL degradation. D 3 -induced HL-60 macrophages also exhibited saturable, specific, receptor-mediated LDL degradation ( Figure IB) . The maximum degradation rate was observed at 27 /ig/ml LDL. At a concentration of 10 ;u,g/ml, 75% of the degradation occurred via a receptor-mediated process. Induction of macrophage differentiation with D 3 resulted in rates of LDL degradation that were virtually identical to those for undifferentiated HL-60 cells. In contrast, macrophage induction of HL-60 cells with TPA resulted in an almost complete loss of receptormediated LDL degradation ( Figure 2 ). These data demonstrate that whereas HL-60 cells could be induced to differentiate into macrophages by both TPA and D 3 , the inducers produce distinctly different effects on the expression of the LDL receptor and receptor-mediated LDL degradation rates. Absence of acetyl-LDL degradation by TPA-induced HL-60 macrophages could be due to either a failure of TPA to induce expression of the acetyl-LDL receptor or an inhibitory effect of TPA on receptor activity, as seen for the LDL receptor. To determine whether TPA blocked the activity of the acetyl-LDL receptor, D 3 -induced HL-60 macrophages, which express acetyl-LDL receptors, were treated with 1.5 x 10~6 M TPA for zero or 2 hours before measurement of acetyl-LDL degradation ( Figure 4 ). Incubation with TPA had no effect on non-receptor-mediated acetyl-LDL degradation; however, receptor-mediated acetyl-LDL degradation was reduced by 85% with TPA treatment, whether added at time zero or after a 2-hour pretreatment. The data indicate that TPA directly blocks receptor-mediated degradation of both LDL and acetyl-LDL by D 3 -induced HL-60 macrophages.
To determine whether the action of TPA on LDL receptor activity was concentration dependent, HL-60 cells were treated with varying concentrations of TPA for 2 or 48 hours, followed by determination of LDL degradation rates ( Figure 5 ). Cells incubated with TPA for 2 hours exhibited a concentration- To examine whether the reduction of receptormediated LDL degradation was unique to TPA, the effect of mezerein, a protein kinase C activator and inducer of macrophage differentiation of HL-60 cells, was used to determine effects on LDL degradation. Cells incubated with 7xlO~8 M mezerein for 48 hours exhibited a 90% reduction in receptormediated LDL degradation relative to D 3 -induced HL-60 macrophages (data not shown). These results suggest involvement of protein kinase C in the TPAand mezerein-mediated inhibitory effects on receptormediated LDL degradation by HL-60 cells. Because only D 3 -induced HL-60 macrophages exhibited both native and modified LDL receptors, subsequent studies to characterize the regulatory responses of these receptors were performed in D 3 -treated HL-60 cells.
Time Courses of Low Density Lipoprotein and Acetylated Low Density Lipoprotein Degradations
Analysis of the time courses of expression of LDL and acetyl-LDL degradation in D 3 -induced HL-60 macrophages are presented in Table 1 . 
Receptor Specificity
To investigate the specificity of receptor-mediated LDL degradation by D 3 -induced HL-60 macrophages, competition studies were performed with various lipoproteins as competitors ( Figure 6 ). Both LDL and VLDL, which contain apo B-100, effectively competed with I-LDL. These data demonstrate the presence of specific apo B/E receptors on D 3 -induced HL-60 macrophages, which recognize and are involved in the degradation of both apo B-and apo E-containing lipoproteins.
I-LDL degradation at 10 ijg/ml (100%) and in the presence of the indicated concentrations of LDL (o), very low density lipoprotein (VLDL) (•), total high density lipoprotein (HDL) (•), apo E-free HDL (•), and acetylated LDL (acetyl-LDL) (o). Values represent mean±SD of six measurements.
EXCESS UNLABELED LIPOPROTEIN (jiq/m\)
The specificity of the scavenger receptor of D 3 -induced HL-60 macrophages was also determined by competition studies (Figure 7 ).
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I-acetyl-LDL degradation was slightly reduced by excess LDL (29%), apo E-free HDL (15%), total HDL (13%), and VLDL (20%). In contrast, excess acetyl-LDL effectively competed with 125 I-acetyl-LDL for scavenger receptor sites, thereby reducing the degradation rate by 75%. The data demonstrate that D 3 -induced HL-60 macrophages possess a specific scavenger receptor that recognizes chemically modified acetyl-LDL.
Regulation Studies
To further characterize the regulation of native and scavenger LDL receptors of D 3 -induced HL-60 macrophages, LDL and acetyl-LDL degradation rates were determined in the presence of calcium (control), in the absence of calcium but with EDTA added, and in the presence of calcium plus pronase, chloroquine (lysosomal enzyme inhibitor), or fucoidin (negatively charged compound that competes with acetyl-LDL for receptor sites) (Figure 8 ). Receptor-mediated LDL degradation by D 3 -induced HL-60 macrophages was reduced 95% with EDTA in the absence of calcium compared with control macrophages. Chloroquine treatment, which inhibits lysosomal degradation, resulted in a 70% reduction in receptor-mediated LDL degradation. macrophages with the proteolytic enzyme pronase resulted in an 80% reduction in LDL degradation compared with control cells. In contrast, receptormediated acetyl-LDL degradation by D 3 -induced HL-60 macrophages exhibited no dependency for calcium ( Figure 8 ). The inhibitory effect of chloroquine was observed for both receptor-and nonreceptor-mediated acetyl-LDL degradations. The receptor was partially sensitive to pronase and fucoidin, with acetyl-LDL degradation rates being significantly reduced by 56% in the presence of pronase Cells were incubated in lipoprotein-deficient fetal calf serum for 24 hours, followed by addition of either 100 /ig/ml LDL or acetyl-LDL for 24 hours and measurement of the incorporation of carbon-14-labeled acetate into sterols. Data are presented as mean±SD for the number of assays shown in parentheses. Values in the same column with different symbols are significantly different (/><0.001).
LDL, low density lipoprotein; acetyl-LDL, acetylated LDL. undifferentiated cells ( Table 2) . Addition of 100 fig/ml LDL to the incubation media resulted in reductions of 54% and 88% in sterol synthesis rates of HL-60 cells and D 3 -induced macrophages, respectively. Incubation with 100 /x.g/ml acetyl-LDL had no effect on the rate of sterol synthesis by HL-60 cells, which lack an acetyl-LDL receptor, and caused a 68% reduction in sterol synthesis rates of D 3 -induced HL-60 macrophages ( Table 2 ). The data demonstrate that the delivery of exogenous cholesterol to macrophages via the degradation of either LDL or acetyl-LDL is capable of suppressing the rate of endogenous sterol synthesis. Discussion HL-60 cells have been shown to be a valuable model for studying chemically induced macrophage or granulocyte differentiation in vitro.
131529 - 31 This cell line, with its bipotential induction characteristics, can be induced to differentiate into granulocytes by dimethyl sulfoxide or retinoic acid and into macrophages in response to TPA and the active forms of vitamin D 3 , specifically, 1,25-dihydroxyvitamin D 3 . In this report we have shown that induction of macrophage differentiation of HL-60 cells by TPA and D 3 exerted distinctly different effects on the activities of receptors for native and modified LDL.
Lipoprotein Receptors of HL-60 Cells
Undifferentiated HL-60 cells exhibited specific, saturable, receptor-mediated LDL degradation. Analysis of LDL degradation rates in cells incubated in media containing 100 ^tg/ml LDL demonstrated low levels of receptor-mediated LDL degradation, which could be induced fourfold by incubating the cells in LPDS. In contrast to the findings of an active and regulated LDL receptor, HL-60 cells failed to degrade acetyl-LDL, indicating the absence of the scavenger receptor. These results confirm the reports of Wathne et al 10 and Via et al, 11 which indicated that HL-60 cells possess LDL receptors but lack acetyl-LDL receptors. In a similar manner, the human monocytic leukemia cell line THP-1 and the human histiocytic lymphoma cell line U-937 have been shown to have native LDL but not modified LDL receptors. 3233 In general, modified LDL receptors are not expressed by nonmacrophage cells. 34 
Effect of Tetramyristic Phorbol Acetate on HL-60 Cells
Treating HL-60 cells with TPA induced differentiation to a macrophage-like cell; however, the macrophages exhibited only 5% of the receptor-mediated LDL degradation rate of HL-60 cells and no detectable receptor-mediated acetyl-LDL degradation. Similar findings regarding expression of LDL and acetyl-LDL receptors by TPA-induced HL-60 macrophages have been reported by Via et al. 11 Comparable inhibitory effects by TPA on LDL receptor activity have also been reported for other cell lines, including MRC5 human fibroblasts, 35 U-937 cells, 33 THP-1 cells, 32 and HEL cells. 36 Studies by Rouis et al 33 and Maziere et al 35 suggest that the TPAmediated reduction in LDL degradation results from a decrease in receptor number and not a change in receptor affinity for LDL. While there appears to be a consistency of reports that TPA treatment reduces receptor-mediated LDL degradation in macrophagelike cells, Auwerx et al 37 reported an induction of LDL receptor mRNA during early macrophage differentiation of THP-1 cells by TPA. These authors provided evidence that the TPA effect was mediated by protein kinase C and that protein kinase C exerted its effect by directly or indirectly inactivating a labile negative protein, rendering it unable to bind to a positive transcription factor and to form an inactive complex. This is consistent with the finding that other protein kinase C activators induce LDL receptor mRNA whereas protein kinase C inhibitors block induction. 37 It would appear, however, that activation of protein kinase C has two effects: induction of LDL receptor mRNA and a decrease in receptor-mediated LDL degradation. Treatment of MRC5 fibroblasts 35 and of D 3 -induced HL-60 macrophages with mezerein, a protein kinase C activator, 38 results in a similar loss of receptor-mediated LDL degradation.
The inhibitory effect of TPA on receptor-mediated LDL uptake is not unique to the LDL receptor in that the binding of other ligands including insulin, 39 -40 insulin-like peptides, 41 transferring 2 and epidermal growth factor 43 are blocked by TPA. It has been hypothesized that TPA treatment alters the activities of a variety of cell surface receptors by receptor masking due to induction of cryptic receptors, 44 covalent modification of receptors, 45 alterations in the ionic milieu secondary to changes in pH or calcium ion activity, 46 or receptor redistribution and increased net internalization. 46 A TPA-mediated reduction in LDL uptake would in part explain the observed increases in the rates of sterol synthesis and HMG-CoA reductase activity of TPA-induced HL-60 macrophages 12 and the increased levels of LDL receptor and HMG-CoA reductase mRNA of TPA-treated THP-1 cells 947 if the feedback suppression of these genes by LDL cholesterol is released due to decreased uptake of LDL.
The effect of TPA treatment on expression of the acetyl-LDL receptor appears to be highly variable in that some studies report decreased scavenger receptor expression while others report an induction of the receptor. The finding reported here, that TPA treatment does not induce expression of the acetyl-LDL receptor in HL-60 cells, has been reported by others. 11 Consistent with the findings that TPA decreases receptor-mediated degradation of acetyl-LDL by D 3 -induced HL-60 macrophages are the reports by Leake et al 48 The finding that mezerein, another protein kinase C activator, mimics the effect of TPA suggests that protein kinase C may be involved in the observed inhibitory effect of TPA on LDL degradation rates of HL-60 cells and macrophages. Macrophage differentiation of HL-60 cells treated with TPA and D 3 involves in part the activation of protein kinase C, which causes the phosphorylation of a number of protein substrates resulting in long-term cellular responses (e.g., differentiation). It has been shown that protein kinase C activates the transcription of LDL receptor mRNA levels during the early differentiation stages of THP-1 cells. 37 However, it is conceivable that the effect of these two inducers on LDL and acetyl-LDL receptors is via different mechanisms, although both inducers have similar effects on protein kinase C and membrane lipids.
-
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- 52 TPA, a homologue of diacylglycerol, activates protein kinase C directly and influences membrane lipids, causing receptor masking, whereas D 3 induces the transcription of several genes including protein kinase C that is independent of phospholipid hydrolysis and diacylglycerol generation. 51 These differential responses to the two inducers of macrophage differentiation may in part explain the findings of this study.
Low Density Lipoprotein Receptor of 1,25-Dihydroxyvitamin D 3 -Induced HL-60 Macrophages
In this report we have demonstrated that D 3 -induced HL-60 macrophages possess both native and modified LDL receptors. Induction of maturation with D 3 for 48 hours resulted in LDL degradation rates identical to those in untreated HL-60 cells. Increasing the time of exposure to D 3 resulted in a 46% decrease in LDL degradation, which remained constant after 4 days in culture. Similar results have been reported for human monocyte-derived macrophages, where the LDL receptor activity either remained constant or increased during the first week in culture and then decreased during the second week. The LDL receptor of D 3 -induced HL-60 macrophages was further characterized to demonstrate that degradation was calcium dependent and that the receptor was a protein, as demonstrated by the inactivation of receptor-mediated degradation with pronase treatment. Similar results have been reported by Goldstein and Brown 55 for the fibroblast apo B/E receptor. After LDL uptake, degradation occurs by lysosomal enzymes, as evidenced by the inhibition of degradation by the lysomotropic compound chloroquine, which decreased both specific and nonspecific degradations. A fourfold induction of the LDL receptor was obtained by preincubating D 3 -induced HL-60 macrophages with LPDS, which is similar to the induction reported for human monocyte-derived macrophages 34 and fibroblasts. 5355 A maximum induction of 6.5-fold for receptor-mediated LDL degradation rates was observed in the presence of LPDS and 1 /AM mevinolin. Mevinolin, which inhibits endogenous cholesterol synthesis, induces LDL receptor synthesis and consequently LDL degradation. 10 Wathne et al 14 Characterization of the scavenger receptor of D 3 -induced HL-60 macrophages indicated that the receptor was calcium independent, chloroquine sensitive, and partially sensitive to pronase and fucoidin. To establish that acetyl-LDL was entering cells via a specific acetyl-LDL receptor pathway, competition studies demonstrated that the scavenger receptor exclusively recognized and degraded acetyl-LDL. Moreover, the scavenger receptor pathway was neither downregulated by pretreating the cells with acetyl-LDL for 24 hours nor induced by preincubating the macrophages in LPDS. In addition, the expression of the acetyl-LDL receptor activity was fully induced within 48 hours of treatment with D 3 , and it remained relatively constant for as long as 6 days in culture. Similar results are reported for TPA-treated THP-1 macrophages, 32 as well as for human monocyte-derived macrophages. The increased sterol synthesis rates may be due to the need for macrophages to expand their cellular membrane during the course of differentiation. D 3 treatment of HL-60 cells was accompanied by an increase in cell volume and consequently by an increase of cellular membrane as reported by Mangelsdorf et al. 15 In the presence of either acetyl-LDL or LDL, D 3 -induced HL-60 macrophages exhibited a reduction in sterol synthesis, indicative of the presence of both native and modified LDL receptors. In addition, a reduction of 88% and 68% in sterol synthesis in the presence of LDL and acetyl-LDL, respectively, demonstrated that the amount of cholesterol delivered to the macrophages from LDL and acetyl-LDL regulated cholesterol synthesis. D 3 induces in HL-60 cells a phenotype that resembles that of monocytes-macrophages.
14 D 3 -induced HL-60 macrophages are the only chemically induced human macrophage system reported to date that possesses functionally active native and modified LDL receptors. Compared with D 3 -induced HL-60 macrophages and human monocyte-derived macrophages, human leukemic (THP-1 and HEL) 323637 and murine cell lines (BALB/c and P388D1) treated with TPA, 11 and mouse peritoneal macrophages 5   -7 express acetyl-LDL receptor with little or no LDL receptor activities.
In conclusion, our findings demonstrate that induction of HL-60 cell differentiation with D 3 results in macrophages exhibiting both a regulated apo B/E receptor and a scavenger receptor whereas induction with phorbol and non-phorbol protein kinase C activators results in an immediate dose-dependent inhibition of LDL degradation and a long-term inhibitory effect on apo B/E receptor-mediated degradation of both LDL and acetyl-LDL. D 3 -treated HL-60 cells represent a potentially valuable model of human macrophages as a homogeneous and readily available cultured cell system that can be used to investigate regulatory mechanisms involved in macrophage-lipoprotein metabolism and the factors involved in macrophage cholesterol flux and foam cell development.
